ESC 365 - PCSK9 inhibitors in clinical practice: expectations and reality

EAPC Premium Access

PCSK9 inhibitors in clinical practice: expectations and reality

Session: Management of dyslipidemia in the setting of cardiovascular prevention and rehabilitation

Topic: Cardiovascular Rehabilitation

Speaker: Professor Z. Reiner (Zagreb, HR)

Event: EuroPrevent 2019

Congress Presentation

Add to my library

About the speaker

Professor Zeljko Reiner

University Hospital Centre Zagreb, Zagreb (Croatia)

6 presentations

1 follower

2 more presentations in this session

Familial hypercholesterolaemia is underdiagnosed and undertreated - Experience from Saudi Arabia

Speaker: Doctor F. Alnouri (Riyadh, SA)

HDL-C, Triglycerides and Lp(a) - Role in the progression of coronary artery disease

Speaker: Professor U. Landmesser (Berlin, DE)

Access the full session

Management of dyslipidemia in the setting of cardiovascular prevention and rehabilitation

Speakers: Professor Z. Reiner, Doctor F. Alnouri, Professor U. Landmesser

About the event

EuroPrevent 2019

11 April - 13 April 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources